144 related articles for article (PubMed ID: 9489411)
1. [Treatment of patients with chronic pulmonary tuberculosis with expectoration--evaluation of effectiveness].
Michałowska-Mitczuk D; Kuś J
Pneumonol Alergol Pol; 1997; 65(3-4):164-71. PubMed ID: 9489411
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of patients for chronic pulmonary tuberculosis with expectoration--selection and tolerance to drugs].
Michałowska-Mitczuk D; Kuś J
Pneumonol Alergol Pol; 1997; 65(3-4):172-80. PubMed ID: 9489412
[TBL] [Abstract][Full Text] [Related]
3. [Reasons for chronic sputum culture positive tuberculosis--evaluation based on personal experience].
Michałowska-Mitczuk D; Kuś J
Pneumonol Alergol Pol; 1997; 65(3-4):157-63. PubMed ID: 9489410
[TBL] [Abstract][Full Text] [Related]
4. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
5. [Reasons for chronic expectoration in patients with pulmonary tuberculosis registered in the Central Tuberculosis Registry].
Korzeniewska-Koseła M; Michałowska-Mitczuk D; Wedzicha S; Pawlicka L; Miller M; Kuś J
Pneumonol Alergol Pol; 1997; 65(3-4):181-6. PubMed ID: 9489413
[TBL] [Abstract][Full Text] [Related]
6. [Reasons for chronic expectoration--case reports].
Michałowska-Mitczuk D; Kuś J
Pneumonol Alergol Pol; 1997; 65(3-4):244-8. PubMed ID: 9489422
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
Prasad R; Verma SK; Sahai S; Kumar S; Jain A
Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
[TBL] [Abstract][Full Text] [Related]
8. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
[TBL] [Abstract][Full Text] [Related]
9. [A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar].
Ramarokoto H; Andrianasolo D; Rasolonavalona T; Ramaroson F; Razafitsiarovana I; Vincent V; Ratsimba L; Rasolofo Razanamparany V
Arch Inst Pasteur Madagascar; 2003; 69(1-2):37-40. PubMed ID: 15678814
[TBL] [Abstract][Full Text] [Related]
10. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].
Shigetoh E; Murakami I; Yokosaki Y; Kurimoto N
Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128
[TBL] [Abstract][Full Text] [Related]
11. Performance of culture and drug susceptibility testing in pulmonary tuberculosis patients in northern China.
Qi W; Harries AD; Hinderaker SG
Int J Tuberc Lung Dis; 2011 Jan; 15(1):137-9. PubMed ID: 21276311
[TBL] [Abstract][Full Text] [Related]
12. Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis.
Kurbatova EV; Gammino VM; Bayona J; Becerra MC; Danilovitz M; Falzon D; Gelmanova I; Keshavjee S; Leimane V; Mitnick CD; Quelapio MI; Riekstina V; Taylor A; Viiklepp P; Zignol M; Cegielski JP
Int J Tuberc Lung Dis; 2012 Oct; 16(10):1335-43. PubMed ID: 23107633
[TBL] [Abstract][Full Text] [Related]
13. In vitro drug resistance and response to therapy in pulmonary tuberculosis patients under a DOTS programme in south India.
Aparna SB; Reddy VC; Gokhale S; Moorthy KV
Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):564-70. PubMed ID: 19243801
[TBL] [Abstract][Full Text] [Related]
14. [The specific features of bacillary excretion and drug sensitivity in Mycobacterium tuberculosis in patients with recurrent pulmonary tuberculosis].
Il'iuna TIa; Zhangireev AA; Sidorenko OA
Probl Tuberk Bolezn Legk; 2008; (5):20-2. PubMed ID: 18711814
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of sparfloxacin in combination with kanamycin and ethionamide in multidrug-resistant pulmonary tuberculosis patients: preliminary results.
Singla R; Gupta S; Gupta R; Arora VK
Int J Tuberc Lung Dis; 2001 Jun; 5(6):559-63. PubMed ID: 11409584
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso.
Sangare L; Diande S; Kouanda S; Dingtoumda BI; Mourfou A; Ouedraogo F; Sawadogo I; Nebie B; Gueye A; Sawadogo LT; Traore AS
Ann Afr Med; 2010; 9(1):15-9. PubMed ID: 20418644
[TBL] [Abstract][Full Text] [Related]
18. Pilot study on multidrug resistant tuberculosis in Nigeria.
Lawson L; Habib AG; Okobi MI; Idiong D; Olajide I; Emenyonu N; Onuoha N; Cuevas LE; Ogiri SO
Ann Afr Med; 2010; 9(3):184-7. PubMed ID: 20710112
[TBL] [Abstract][Full Text] [Related]
19. Recurrence after successful treatment among patients with multidrug-resistant tuberculosis.
Lee J; Lim HJ; Cho YJ; Park YS; Lee SM; Yang SC; Yoo CG; Kim YW; Han SK; Yim JJ
Int J Tuberc Lung Dis; 2011 Oct; 15(10):1331-3. PubMed ID: 22283890
[TBL] [Abstract][Full Text] [Related]
20. [Multidrug pulmonary tuberculosis: sociomedical features and the efficiency of inpatient treatment].
Filiniuk OV; Ianova GV; Strelis AK; Urazova OI; Zemlianaia NA; Buĭnova LN; Voronkova OV; Ianov SA; Shchegertsov DIu
Probl Tuberk Bolezn Legk; 2008; (8):23-8; discussion 28. PubMed ID: 18819334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
